Loading…
Launch Readiness for Medical Affairs & Communications Teams has ended

Sign up or log in to bookmark your favorites and sync them to your phone or calendar.

Thursday, February 4
 

11:00am EST

Opening Remarks
Speakers
avatar for Peter Goldberg, Ph.D.

Peter Goldberg, Ph.D.

Head of Medical Science Liaisons, East US; Rheumatolgy Medical Team, UCB
Peter L. Goldberg, PhD. is an award-winning Field Medical Affairs Leader with proven professional experience in pharmaceutical medical affairs and leadership with abilities in strategic planning, field associate mentoring/coaching, aligning resources for maximum impact, and change... Read More →


Thursday February 4, 2021 11:00am - 11:05am EST

11:05am EST

Keynote: Demonstrate How the Role of Medical Affairs is Critical in Ensuring a Successful Launch
  • Explore how the role of medical affairs during launch readiness is evolving 
  • Evaluate how the role of medical affairs can serve as a bridge between internal company stakeholders (R&D, commercial, regulatory, & market access) and external stakeholders 
  • Discuss how life science companies can benefit medical affairs being involved early in the drug development stage 




Speakers
avatar for Kirk Shepard, MD

Kirk Shepard, MD

Chief Medical Officer & SVP, Head of Global Medical Affairs OBG, Eisai, Inc.
Dr. Kirk Shepard is a board-certified medical oncologist and hematologist physician. He is currently CMO and Senior Vice President, Head of Global Medical Affairs Oncology at Eisai Inc. Pharmaceutical Company.  Dr. Shepard’s experience in multiple therapeutic areas includes diverse... Read More →


Thursday February 4, 2021 11:05am - 11:30am EST

11:35am EST

Optimize the Handoff to Medical Affairs: How Can Medical & Commercial Collaborate More Effectively?

  • Analyze the different operating models used by small/big pharma, biotech, and diagnostics 
  • Deliberate over the point in time at which a new product should be handed over to medical affairs from commercial new product planning and how the handoff should be coordinated 
  • Create strategic & tactical alignment between commercial and medical while budgeting and goal building 


Moderators
avatar for Oscar Segurado, MD, PhD

Oscar Segurado, MD, PhD

Chief Medical Officer, ASC Therapeutics
Executive veteran of the biopharmaceutical industry with extensive global leadership experience in medical affairs, clinical development and translational science.Chief Medical Officer for ASC Therapeutics, formerly for Symvivo, Myriad Genetics-Crescendo and CellMax Life, Vice... Read More →

Speakers
avatar for Sonal Bhatia, MD

Sonal Bhatia, MD

Vice President, North America Medical Lead, Rare Disease, Pfizer
Sonal Bhatia, MD is the Vice President, Medical Affairs and North America Lead for Rare Disease at Pfizer. In this role, Sonal leads US and Canada Medical Affairs colleagues, including Field-based Medical colleagues and is responsible for the development and execution of regional... Read More →
avatar for Damon Harrell

Damon Harrell

Vice President, Marketing, Psychiatry Franchise, Alkermes
With over 25 years of pharmaceutical experience, Damon Harrell has held a broad range of positions across multiple therapeutic areas, multiple geographies and product lifecycle responsibilities including new products, multiple product launches and line extensions, and patent expiration.  Damon... Read More →
avatar for Alan Wright, MD, MPH

Alan Wright, MD, MPH

Chief Medical Officer, Roche
As the Chief Scientific Officer for Roche Diagnostics Corporation, Dr. Wright serves as its lead clinical and policy spokesperson on all aspects of clinical diagnostic medicine. As a physician with extensive background in the managed care, pharmaceutical, clinical laboratory, and... Read More →


Thursday February 4, 2021 11:35am - 12:20pm EST

12:20pm EST

"Meet the Speakers" Zoom Party
Missing out on the networking aspect of live events? Your question didn’t get answered during the Q&A portion of a session? Grab a snack and mingle with today’s speakers and attendees in these zoom breakout room

Thursday February 4, 2021 12:20pm - 12:50pm EST

12:50pm EST

Actionable Insights for Medical Affairs Teams: Lessons from the Front Lines
  • Leverage deep KOL relationships and technology for insight generation.
  • Explore a real-world case study in facilitating knowledge transfer with a strong pedagogical approach.
  • It’s all about data, data, data.
  • And then COVID, and the big pivot

Speakers
avatar for Christina L. Hoffman, MS

Christina L. Hoffman, MS

Global Head, Medscape Medical Affairs
Christina (Chris) Hoffman joined Medscape/WebMD 13 years ago to serve as a Cardiovascular strategist in education. She was promoted to Executive Director/Team Lead with business development leadership responsibility for Diabetes, Obesity and Dyslipidemia education support.   She... Read More →
avatar for Jim Januzzi, MD

Jim Januzzi, MD

Director, Dennis and Marilyn Barry Fellowship in Cardiology Research, Massachusetts General Hospital
Dr. Jim Januzzi has been a member of the Massachusetts General Hospital Cardiology Division since 2000.  He is the Hutter Family Professor of Medicine at Harvard Medical School and is on faculty at the Harvard Clinical Research Institute.Dr. Januzzi graduated first in his class from... Read More →


Thursday February 4, 2021 12:50pm - 1:20pm EST

1:25pm EST

Panel Discussion: Improve Your KOL Engagement and Management Strategy
  • Learn how to strategically map and segment national, regional, and local KOL’s 
  • Discuss innovative ways to digitally engage with KOL’s during Covid-19 
  • Consider how digital opinion leaders, including patient advocates, new doctors, and social media influencers are changing the game 

Moderators
avatar for Sue Currie, Ph.D.

Sue Currie, Ph.D.

Vice President, Head of Medical Affairs, Nektar Therapeutics
Dr. Sue Currie is the VP, Head of Medical Affairs at Nektar Therapeutics, a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Nektar Therapeutics has a deep and diverse portfolio of investigational... Read More →

Speakers
avatar for Carol Hoang, PharmD, MBA

Carol Hoang, PharmD, MBA

Vice President, Medical Affairs, Adverum Biotechnologies
Carol Hoang is a pharmaceutical and healthcare executive with 15+ years of experience across multiple sectors of the healthcare industry including biotech, pharmaceutical, managed care, specialty distribution, and digital health.  Experience includes domestic and international markets... Read More →
avatar for Mark Wildgust, Ph.D.

Mark Wildgust, Ph.D.

Vice President, Global Medical Affairs, Oncology, Janssen
Mark Wildgust has spent more than 20 years in the pharmaceutical industry working primarily in oncology, hematology and virology. He completed his undergraduate degree in Biological Sciences at the University of Plymouth, UK, and his PhD in Trace Metal Toxicology at the University... Read More →
avatar for Steven Zhang, MD, Ph.D.

Steven Zhang, MD, Ph.D.

Senior Vice President, Medical Affairs, Kala Pharmaceuticals
Steven Zhang, MD, PhD is the Senior Vice President, Medical Affairs and Drag Safety at Kala Pharmaceuticals. Dr. Zhang has over 15 years of experience in pharmaceutical medical affairs with 11+ years in the ophthalmic industry. Prior to joining Kala in 2018, Dr. Zhang was the Head... Read More →


Thursday February 4, 2021 1:25pm - 2:10pm EST

2:10pm EST

"Meet the Speakers" Zoom Party
Missing out on the networking aspect of live events? Your question didn’t get answered during the Q&A portion of a session? Grab a snack and mingle with today’s speakers and attendees in these zoom breakout room

Thursday February 4, 2021 2:10pm - 2:40pm EST

2:40pm EST

Apply Real World Evidence to Communications Strategies to Achieve Launch Excellence
  • Understand the role and value of RWE for product launch 
  • Discuss potential timings of RWE strategy and development 
  • Evaluate different types of evidence and how they can potentially fill data gaps 
  • Explore how impactful RWE can be when assessed in a cross functional platform 



Speakers
avatar for Sonal Bhatia, MD

Sonal Bhatia, MD

Vice President, North America Medical Lead, Rare Disease, Pfizer
Sonal Bhatia, MD is the Vice President, Medical Affairs and North America Lead for Rare Disease at Pfizer. In this role, Sonal leads US and Canada Medical Affairs colleagues, including Field-based Medical colleagues and is responsible for the development and execution of regional... Read More →


Thursday February 4, 2021 2:40pm - 3:10pm EST

3:15pm EST

Late Stage Commercial Launch Preparedness from a People, Process, and Technology Perspective
  • Review selected industry trends that are shaping how Late-Stage Companies are preparing for Commercial Launch
  • Understand key milestones along the pathway to Commercial Launch
  • Examine the role of Medical Operations in preparing for Commercial Launch
  • Learn how to establish critical content management infrastructure to support Commercial Launch
  • Explore a Case Study and apply lessons learned

Speakers
avatar for Rebecca Burnett, MS, MBA

Rebecca Burnett, MS, MBA

Executive Director and Head of Strategic Services, Framework Solutions
As Executive Director of Strategic Services, Rebecca is responsible for the strategic direction, growth, and success of client engagements within the Pharmaceutical and Life Sciences industry for Framework Solutions.Rebecca began her career in 1999 with SmithKline Beecham as a Clinical... Read More →


Thursday February 4, 2021 3:15pm - 4:00pm EST

4:00pm EST

"Meet the Speakers" Zoom Party
Thursday February 4, 2021 4:00pm - 5:00pm EST
 
Friday, February 5
 

11:00am EST

Opening Remarks
Speakers
avatar for Peter Goldberg, Ph.D.

Peter Goldberg, Ph.D.

Head of Medical Science Liaisons, East US; Rheumatolgy Medical Team, UCB
Peter L. Goldberg, PhD. is an award-winning Field Medical Affairs Leader with proven professional experience in pharmaceutical medical affairs and leadership with abilities in strategic planning, field associate mentoring/coaching, aligning resources for maximum impact, and change... Read More →


Friday February 5, 2021 11:00am - 11:05am EST

11:05am EST

Keynote: What Does Medical Affairs Success Look Like in a Virtual World?
  • Define medical affairs success and what it looks like during Covid-19 
  • Identify what it means to have a successful engagement from a medical vs. commercial perspective 
  • Discuss how the major KPIs have morphed and how to achieve them 
  • Consider new tools MSLs need for field success and territory optimization 

Speakers
avatar for Kirk Taylor, MD

Kirk Taylor, MD

Senior Vice President, Regional Medical Affairs, North America, EMD Serono
Kirk Taylor, MD is a senior executive in the pharmaceutical industry with over 22 years of experience leading global teams, championing late phase development, and transforming medical departments.  His breadth of industry knowledge stems from his roles as Chief Medical Officer... Read More →


Friday February 5, 2021 11:05am - 11:30am EST

11:35am EST

Panel: Successfully Integrate the Patient Voice into your Medical Communications
  • Discuss the advantages and disadvantages that Covid-19 has had on how we communicate with patients 
  • Identify opportunities to partner with patient advocacy groups and determine who is the best partner for your company  
  • Create and measure tangible goals relating to patient centricity that are important to stakeholders 

Moderators
avatar for Carol Hoang, PharmD, MBA

Carol Hoang, PharmD, MBA

Vice President, Medical Affairs, Adverum Biotechnologies
Carol Hoang is a pharmaceutical and healthcare executive with 15+ years of experience across multiple sectors of the healthcare industry including biotech, pharmaceutical, managed care, specialty distribution, and digital health.  Experience includes domestic and international markets... Read More →

Speakers
avatar for Heather Ambrose

Heather Ambrose

Director of Acute Care Field Medical and Patient Advocacy, BTG
Heather is the Director of Acute Care Field Medical and Patient Advocacy at BTG Specialty Pharmaceuticals, a division of Boston Scientific.  In over 20 years in the pharmaceutical industry, she has held various roles in commercial management, market access, medical affairs, and patient... Read More →
avatar for Ashish Dugar, Ph.D, MBA

Ashish Dugar, Ph.D, MBA

Vice President, Global Medical Affairs, Sarepta Therapeutics
Dr. Ashish “Ash” Dugar is a business leader with experience in clinical development & medical affairs, market access & health economics, commercial & business development, and new product assessment. He has a deep understanding of the global healthcare environment, market trends... Read More →
avatar for Anand Reddi, MD

Anand Reddi, MD

Director, Digital Innovation, Global Commercial Strategy & Operations, Gilead Sciences
Anand Reddi is Director of Digital Innovation at Gilead Sciences Inc.  Since joining Gilead in 2014, Anand has held several positions with experiences in Access Operations & Emerging Markets, Public Health & Medical Affairs, International Operations & Corporate Affairs, Corporate... Read More →


Friday February 5, 2021 11:35am - 12:20pm EST

12:20pm EST

"Meet the Speakers" Zoom Party
Missing out on the networking aspect of live events? Your question didn’t get answered during the Q&A portion of a session? Grab a snack and mingle with today’s speakers and attendees in these zoom breakout room

Friday February 5, 2021 12:20pm - 12:50pm EST

12:50pm EST

Best Practices for Approaches for Launch Planning for Evidence Generation in Oncology

  • Learn how to think strategically about evidence generation planning to support a successful evidence plan
  • Break apart how you should consider unmet need and clinical/value story in evidence generation planning
  • Essential elements and steps towards creating a successful and effective evidence plan
  • Learn best practice approaches in turning evidence into an actionable launch plan to communicate your clinical and value story


Speakers
avatar for Mark Wildgust, Ph.D.

Mark Wildgust, Ph.D.

Vice President, Global Medical Affairs, Oncology, Janssen
Mark Wildgust has spent more than 20 years in the pharmaceutical industry working primarily in oncology, hematology and virology. He completed his undergraduate degree in Biological Sciences at the University of Plymouth, UK, and his PhD in Trace Metal Toxicology at the University... Read More →


Friday February 5, 2021 12:50pm - 1:20pm EST

1:25pm EST

Panel: Assess the Implications of Remote Publication Planning
  • Make quick and effective decisions when faced with delayed clinical results and changing review timelines 
  • Evaluate the new compliance challenges that come with virtual medical communication 
  • Analyze potential advantages of virtual congresses for presenting new data  

Moderators
avatar for Chirag Shah, PharmD, RPh

Chirag Shah, PharmD, RPh

Head of Strategic Publications and Medical Education, Neurocrine Biosciences
Chirag Shah is a results-driven Medical Affairs Professional, Pharmacist, Speaker, Advisor, and Leader with vast experiences across clinical, academic, and industrial environments. His areas of expertise include medical affairs strategy and communications, publication planning and... Read More →

Speakers
avatar for Robin LeWinter, Ph.D.

Robin LeWinter, Ph.D.

Senior Director, Medical Communications, Orchard Therapeutics
Robin LeWinter obtained her PhD in Neuroscience from the University of California, San Francisco, followed by a post-doc. Robin has over 15 years of experience in the field of Medical Affairs, with a focus on communications and publications, at several small and mid-sized pharmaceutical... Read More →
avatar for Kris Schuler, MS

Kris Schuler, MS

Director, Global Scientific Publications, Pfizer
Kris is a strategic leader with 20 years pharmaceutical experience within headquarters (global and US medical affairs) and field-based roles (medical affairs and commercial) at several pharmaceutical companies. She also has a decade of work experience at a large medical communication... Read More →
avatar for Dikran Toroser, Ph.D., CMPP

Dikran Toroser, Ph.D., CMPP

Director, Publications Group Lead, Rare Diseases, Neuroscience, Takeda
Dikran has a research background. Following a 15 year spell in academia, Dikran switched to industry and has worked in the last 12 years as a publication planning lead at Amgen Inc, followed by his current position as Director, Publications  Group Lead at Takeda Inc. He is a... Read More →


Friday February 5, 2021 1:25pm - 2:10pm EST

2:10pm EST

"Meet the Speakers" Zoom Party
Missing out on the networking aspect of live events? Your question didn’t get answered during the Q&A portion of a session? Grab a snack and mingle with today’s speakers and attendees in these zoom breakout room

Friday February 5, 2021 2:10pm - 2:40pm EST

2:40pm EST

Analyze Virtual Communication Strategies from a Medical Affairs Perspective
  • Explore specific ways to effectively and virtually share information with HCPs and hospital systems
  • Outline the potential compliance risks that come with virtual engagement
  • Examine how to adapt to changing timeframes due to Covid-19

Speakers
avatar for Eddie Power, PhD

Eddie Power, PhD

Vice President, North America Medical Affairs, Hospital Business, Pfizer
Eddie Power PhD MBA is currently the VP, North America Medical Affairs, Hospital Business at Pfizer and has held positions of increasing responsibility during his career in the pharmaceutical industry.  He started at Pfizer in 2010 leading US teams in Vaccines and Infectious Diseases... Read More →


Friday February 5, 2021 2:40pm - 3:10pm EST

3:15pm EST

Panel Discussion: Dissect the Evolution of the MSL Role and Innovative Ways to Operate During Covid-19
  • Assess the value that MSLs bring to the table and how this value has been affected by the global pandemic 
  • Tackle MSL recruitment challenges faced when hiring and contracting 
  • Evaluate how to internally report and apply MSL insights 
  • Explore innovative training techniques to optimize field MSL interactions and communications 

Moderators
avatar for Peter Goldberg, Ph.D.

Peter Goldberg, Ph.D.

Head of Medical Science Liaisons, East US; Rheumatolgy Medical Team, UCB
Peter L. Goldberg, PhD. is an award-winning Field Medical Affairs Leader with proven professional experience in pharmaceutical medical affairs and leadership with abilities in strategic planning, field associate mentoring/coaching, aligning resources for maximum impact, and change... Read More →

Speakers
avatar for Rachele Berria, MD, Ph.D.

Rachele Berria, MD, Ph.D.

Vice President, Head of Medical US BioPharmaceuticals, AstraZeneca
Rachele is a key player in 10+ novel MoA-based therapies (discovery, development and patient fruition) in both Academic and Industry setting. She is a pioneer of the use of technology (wearables, predictive analytics/AI) and novel clinical endpoints to uncover treatment responders and... Read More →
avatar for Aswin Chandrakantan, MD

Aswin Chandrakantan, MD

Chief Medical Officer, Komodo Health
Aswin Chandrakantan, MD, is Chief Medical Officer at Komodo Health. Prior to Komodo, he was a senior leader in Google’s Global Operations and Strategy which was responsible for the implementation and support for Google’s 240+ ad products sustaining $110B annually in revenue. He... Read More →
avatar for Tyke White, MBA, MPH

Tyke White, MBA, MPH

Vice President, Scientific Engagement and Medical Information, Alkermes
Tyke White, MPH, MBA is Vice President of Scientific Engagement and Medical Information within Medical Affairs at Alkermes.  Tyke has over 30 years’ experience in the pharmaceutical industry holding a variety of positions mostly within Medical Affairs.  Prior to joining Alkermes... Read More →


Friday February 5, 2021 3:15pm - 4:00pm EST